Kopp Investment Advisors’s AngioDynamics ANGO Stock Holding History

Kopp Investment Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-141,923	Closed	-$2.33M	–	66
2015 Q2	$2.33M	Buy	141,923 +460	+0.3%	+$7.64K	1.04%	26
2015 Q1	$2.52M	Sell	141,463 -2,005	-1%	-$37.3K	1.11%	22
2014 Q4	$2.73M	Sell	143,468 -15,820	-10%	-$268K	1.31%	21
2014 Q3	$2.19M	Sell	159,288 -28,380	-15%	-$405K	1.08%	23
2014 Q2	$3.06M	Sell	187,668 -34,171	-15%	-$495K	1.41%	18
2014 Q1	$3.49M	Buy	221,839 +38,619	+21%	+$629K	1.47%	17
2013 Q4	$3.14M	Buy	183,220 +5,505	+3%	+$84.7K	1.42%	21
2013 Q3	$2.35M	Sell	177,715 -11,401	-6%	-$134K	0.86%	26
2013 Q2	$2.13M	Buy	+189,116	New	+$2.01M	0.83%	28

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Kopp Investment Advisors's ANGO Position: Q3 2015 in Review

Kopp Investment Advisors sold out of AngioDynamics (ANGO) in Q3 2015, closing a stake of 141,923 shares — an estimated $2.33M sold.

Kopp Investment Advisors first reported a position in ANGO in Q2 2013 and held it in 9 quarters. The position peaked at $3.49M in Q1 2014. 117 funds tracked by Wall St. Rank hold ANGO as of Q3 2015.

Kopp Investment Advisors reported no remaining AngioDynamics position as of Q3 2015 after selling out during the quarter.
Kopp Investment Advisors sold 141,923 AngioDynamics shares in Q3 2015, an estimated $2.33M.
Kopp Investment Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 9 quarters.
Kopp Investment Advisors's AngioDynamics position peaked at $3.49M in Q1 2014.
117 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2015.

Based on Kopp Investment Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.